$0.75
Live
0.99%
Downside
Day's Volatility :5.69%
Upside
4.75%
37.64%
Downside
52 Weeks Volatility :71.65%
Upside
54.55%
Period | Cosmos Health Inc | Index (Russel 2000) |
---|---|---|
3 Months | -30.49% | 0.0% |
6 Months | 61.38% | 0.0% |
1 Year | -22.31% | 0.0% |
3 Years | -99.08% | -23.0% |
Market Capitalization | 14.1M |
Book Value | $1.81 |
Earnings Per Share (EPS) | -2.28 |
PEG Ratio | 0.0 |
Wall Street Target Price | 4.0 |
Profit Margin | -38.19% |
Operating Margin TTM | -18.95% |
Return On Assets TTM | -20.23% |
Return On Equity TTM | -56.61% |
Revenue TTM | 56.5M |
Revenue Per Share TTM | 3.73 |
Quarterly Revenue Growth YOY | 6.800000000000001% |
Gross Profit TTM | 8.3M |
EBITDA | -19.9M |
Diluted Eps TTM | -2.28 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.48 |
EPS Estimate Next Year | -0.05 |
EPS Estimate Current Quarter | -0.14 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 433.33%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 37.1M | ↑ 23.56% |
Net Income | -9.1M | ↑ 45.91% |
Net Profit Margin | -24.43% | ↓ 3.74% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 39.7M | ↑ 6.99% |
Net Income | -3.3M | ↓ 63.59% |
Net Profit Margin | -8.31% | ↑ 16.12% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 55.4M | ↑ 39.65% |
Net Income | 820.8K | ↓ 124.88% |
Net Profit Margin | 1.48% | ↑ 9.79% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 56.2M | ↑ 1.5% |
Net Income | -8.0M | ↓ 1070.0% |
Net Profit Margin | -14.16% | ↓ 15.64% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 50.3M | ↓ 10.48% |
Net Income | -13.8M | ↑ 73.71% |
Net Profit Margin | -27.47% | ↓ 13.31% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 53.4M | ↑ 6.02% |
Net Income | -18.5M | ↑ 34.07% |
Net Profit Margin | -34.74% | ↓ 7.27% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 12.3M | ↑ 2.48% |
Net Income | -459.9K | ↓ 95.75% |
Net Profit Margin | -3.72% | ↑ 86.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 12.4M | ↑ 0.11% |
Net Income | -981.5K | ↑ 113.44% |
Net Profit Margin | -7.94% | ↓ 4.22% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 12.8M | ↑ 3.72% |
Net Income | -3.3M | ↑ 241.22% |
Net Profit Margin | -26.12% | ↓ 18.18% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 15.8M | ↑ 23.52% |
Net Income | -13.8M | ↑ 310.61% |
Net Profit Margin | -86.82% | ↓ 60.7% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 14.6M | ↓ 7.93% |
Net Income | -1.9M | ↓ 86.43% |
Net Profit Margin | -12.8% | ↑ 74.02% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 13.2M | ↓ 9.45% |
Net Income | -2.6M | ↑ 38.79% |
Net Profit Margin | -19.62% | ↓ 6.82% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 20.7M | ↑ 93.85% |
Total Liabilities | 24.0M | ↑ 75.23% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 23.9M | ↑ 15.39% |
Total Liabilities | 30.3M | ↑ 26.35% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 43.8M | ↑ 83.61% |
Total Liabilities | 48.0M | ↑ 58.22% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 49.4M | ↑ 12.74% |
Total Liabilities | 45.0M | ↓ 6.16% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 68.0M | ↑ 37.65% |
Total Liabilities | 28.4M | ↓ 37.0% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 66.0M | ↓ 2.97% |
Total Liabilities | 30.0M | ↑ 5.6% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 68.0M | ↓ 0.03% |
Total Liabilities | 23.6M | ↓ 16.72% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 68.6M | ↑ 0.85% |
Total Liabilities | 24.6M | ↑ 3.87% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 71.5M | ↑ 4.28% |
Total Liabilities | 27.0M | ↑ 9.8% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 66.0M | ↓ 7.7% |
Total Liabilities | 30.0M | ↑ 11.18% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 62.3M | ↓ 5.56% |
Total Liabilities | 27.8M | ↓ 7.25% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 60.8M | ↓ 2.43% |
Total Liabilities | 28.7M | ↑ 3.27% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.6M | ↓ 82.25% |
Investing Cash Flow | -195.8K | ↑ 1252.11% |
Financing Cash Flow | 2.0M | ↓ 78.6% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -4.8M | ↑ 207.9% |
Investing Cash Flow | 588.9K | ↓ 400.82% |
Financing Cash Flow | 3.6M | ↑ 80.42% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -11.5M | ↑ 140.18% |
Investing Cash Flow | -117.7K | ↓ 119.99% |
Financing Cash Flow | 12.5M | ↑ 247.35% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -7.1M | ↓ 38.29% |
Investing Cash Flow | -826.8K | ↑ 602.22% |
Financing Cash Flow | 7.3M | ↓ 41.67% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -10.3M | ↑ 80.39% |
Investing Cash Flow | -4.5M | ↑ 13.26% |
Financing Cash Flow | 30.6M | ↑ 1263.05% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.7M | ↓ 44.57% |
Investing Cash Flow | -4.0M | ↓ 11.71% |
Financing Cash Flow | -184.2K | ↓ 100.6% |
Sell
Neutral
Buy
Cosmos Health Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Cosmos Health Inc | -21.54% | 61.38% | -22.31% | -99.08% | -99.08% |
Cardinal Health, Inc. | 0.51% | 9.32% | 22.2% | 129.13% | 122.99% |
Cencora Inc | 3.99% | 0.24% | 25.74% | 62.86% | 96.16% |
Mckesson Corporation | 0.83% | -3.44% | 13.16% | 145.76% | 245.57% |
Henry Schein, Inc. | 1.06% | 0.49% | 7.39% | -8.38% | 15.09% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Cosmos Health Inc | NA | NA | 0.0 | -0.48 | -0.57 | -0.2 | NA | 1.81 |
Cardinal Health, Inc. | 32.58 | 32.58 | 0.96 | 7.36 | 0.0 | 0.03 | 0.02 | -13.17 |
Cencora Inc | 25.59 | 25.59 | 1.33 | 13.63 | 1.88 | 0.03 | 0.01 | 4.7 |
Mckesson Corporation | 22.73 | 22.73 | 1.48 | 27.59 | 0.0 | 0.04 | 0.01 | -13.53 |
Henry Schein, Inc. | 26.45 | 26.45 | 1.6 | 4.75 | 0.07 | 0.04 | NA | 27.64 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Cosmos Health Inc | Buy | $14.1M | -99.08% | NA | -38.19% |
Cardinal Health, Inc. | Hold | $27.2B | 122.99% | 32.58 | 0.38% |
Cencora Inc | Buy | $46.2B | 96.16% | 25.59 | 0.65% |
Mckesson Corporation | Buy | $66.0B | 245.57% | 22.73 | 0.94% |
Henry Schein, Inc. | Hold | $9.1B | 15.09% | 26.45 | 2.82% |
Insights on Cosmos Health Inc
Revenue is down for the last 3 quarters, 15.83M → 13.20M (in $), with an average decrease of 8.7% per quarter
Netprofit is down for the last 2 quarters, -1.86M → -2.59M (in $), with an average decrease of 38.8% per quarter
In the last 1 year, Cencora Inc has given 25.8% return, outperforming this stock by 48.9%
BlackRock Inc
Vanguard Group Inc
Geode Capital Management, LLC
State Street Corp
Northern Trust Corp
Group One Trading, LP
Organization | Cosmos Health Inc |
Employees | 123 |
CEO | Mr. Grigorios Siokas |
Industry | Miscellaneous |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$0.75
-5.3%
Invesco Bulletshares 2025 Hi
$0.75
-5.3%
Schwab International Dividend Equity Etf
$0.75
-5.3%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$0.75
-5.3%
Lightpath Technologies Inc
$0.75
-5.3%
Vaneck Vectors Global Alternative Energy Etf
$0.75
-5.3%
First Trust Flexible Municipal High Income Etf
$0.75
-5.3%
Drx Dly Reg Bank Bull 3x
$0.75
-5.3%
Graniteshares 2x Long Pltr Daily Etf
$0.75
-5.3%